HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners.

Abstract
Stimulation of double-stranded (ds)RNA receptors can increase the effectiveness of cancer vaccines, but the underlying mechanisms are not completely elucidated. In this study, we sought to determine critical roles of host IFN-alpha and IFN-gamma pathways in the enhanced therapeutic efficacy mediated by peptide vaccines and polyinosinic-polycytidylic acid [poly(I:C)] stabilized by lysine and carboxymethylcellulose (poly-ICLC) in the murine central nervous system (CNS) GL261 glioma. C57BL/6-background wild type (WT), IFN-alpha receptor-1 (IFN-alphaR1)(-/-) or IFN-gamma(-/-) mice bearing syngeneic CNS GL261 glioma received subcutaneous (s.c.) vaccinations with synthetic peptides encoding CTL epitopes with or without intramuscular (i.m.) injections of poly-ICLC. The combinational treatment induced a robust transcription of CXCL10 in the glioma site. Blockade of CXCL10 with a specific monoclonal antibody (mAb) abrogated the efficient CNS homing of antigen-specific type-1 CTL (Tc1). Both IFN-alphaR(-/-) and IFN-gamma(-/-) hosts failed to up-regulate the CXCL10 mRNA and recruit Tc1 cells to the tumor site, indicating non-redundant roles of type-1 and type-2 IFNs in the effects of poly-ICLC-assisted vaccines. The efficient trafficking of Tc1 also required Tc1-derived IFN-gamma. Our data point to critical roles of the host-IFN-alpha and IFN-gamma pathways in the modulation of CNS glioma microenvironment, and the therapeutic effectiveness of poly-ICLC-assisted glioma vaccines.
AuthorsXinmei Zhu, Beth A Fallert-Junecko, Mitsugu Fujita, Ryo Ueda, Gary Kohanbash, Edward R Kastenhuber, Heather A McDonald, Yan Liu, Pawel Kalinski, Todd A Reinhart, Andres M Salazar, Hideho Okada
JournalCancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 59 Issue 9 Pg. 1401-9 (Sep 2010) ISSN: 1432-0851 [Electronic] Germany
PMID20549206 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Blocking
  • Cancer Vaccines
  • Chemokine CXCL10
  • Epitopes, T-Lymphocyte
  • Peptide Fragments
  • Receptor, Interferon alpha-beta
  • Polylysine
  • poly ICLC
  • Interferon-gamma
  • Carboxymethylcellulose Sodium
  • Poly I-C
Topics
  • Animals
  • Antibodies, Blocking (administration & dosage)
  • Cancer Vaccines
  • Carboxymethylcellulose Sodium (administration & dosage, analogs & derivatives)
  • Cell Line, Tumor
  • Cell Movement (drug effects, genetics, immunology)
  • Central Nervous System Neoplasms (immunology, pathology, therapy)
  • Chemokine CXCL10 (biosynthesis, genetics, immunology)
  • Epitopes, T-Lymphocyte (chemistry)
  • Glioma (immunology, pathology, therapy)
  • Immunization
  • Interferon-gamma (genetics)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neoplasm Transplantation
  • Peptide Fragments (administration & dosage, chemistry)
  • Poly I-C (administration & dosage)
  • Polylysine (administration & dosage, analogs & derivatives)
  • Receptor, Interferon alpha-beta (genetics)
  • T-Lymphocytes, Cytotoxic (drug effects, immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: